Wird geladen...

Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors

This study uses wholesale medication acquisition costs and Medicare claims data to assess how prices of existing tumor necrosis factor inhibitors changed in response to the market entry of new tumor necrosis factor inhibitors.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA Intern Med
Hauptverfasser: San-Juan-Rodriguez, Alvaro, Prokopovich, Max V., Shrank, William H., Good, Chester B., Hernandez, Inmaculada
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Medical Association 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503568/
https://ncbi.nlm.nih.gov/pubmed/30776053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.7656
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!